This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Consejo Superior De Investigaciones Cientificas, Fundacion Imabis. Instituto Mediterraneo Para El Avance De La Biotecnologia Y La Investigacion Sanitaria. Active years: 2012.
Company Filing History:
1 out of 477 
1 out of 1 Years Active: 2012
Title: Manuel Macias Gonzalez: Innovator in Acyclic Sulfamide Derivatives
Introduction
Manuel Macias Gonzalez is a notable inventor based in Málaga, Spain. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on acyclic sulfamide derivatives. His research focuses on developing compounds that can aid in various health-related applications.
Latest Patents
Manuel holds 1 patent for his invention titled "Acyclic sulfamide derivatives." This patent is related to compounds that are useful for the manufacture of a medicament aimed at inducing satiety and controlling ingestion. Additionally, these derivatives play a role in modulating corporal fat and regulating lipid metabolism. They are also beneficial for the treatment or prevention of diabetes and cardiovascular diseases, and have potential applications in cosmetic use.
Career Highlights
Throughout his career, Manuel has worked with several esteemed organizations. He has been associated with Fundación IMABIS, Instituto Mediterráneo para el Avance de la Biotecnología y la Investigación Sanitaria, and Consejo Superior de Investigaciones Científicas. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Manuel has collaborated with notable colleagues, including Fernando Antonio Rodriguez De Fonseca and Javier Pavon Moron. These partnerships have enriched his research endeavors and fostered innovation in his field.
Conclusion
Manuel Macias Gonzalez is a distinguished inventor whose work on acyclic sulfamide derivatives has the potential to impact health and wellness significantly. His contributions to medicinal chemistry and collaboration with esteemed institutions highlight his commitment to advancing scientific knowledge.